Isconova initiates collaboration with Narvac
Isconova initiates collaboration with NPO Narvac (”Narvac”) – one of Russia’s leading companies within veterinary medicine. Initially, the aim is to develop a rabies vaccine for dog and cat for the Russian market. Isconova will own all clinical data and in addition own the commercial rights for the vaccines throughout the rest of the world, except for China, where Isconova and Narvac will co-operate through a joint venture.
The agreement includes the use of Isconova’s adjuvants for developing more efficient veterinary vaccines. The first product is a Matrix M™ based rabies vaccine for dog and cat – a therapeutic area with great demand. Isconovas Matrix M™ is an adjuvant designed to stimulate the immune system and improve the effect and duration of vaccines.
”We will build commercial success by offering top quality adjuvants and run our own vaccine projects within large therapeutic areas. Thereby, the Narvac co-operation is an important step for us where we will own the commercial rights outside of Russia. The ambition is to introduce the rabies vaccine on the Russian market by end of 2011, after which we will prepare for launch on additional markets”, comments Isconova’s CEO Lena Söderström.
When the vaccine is introduced on the Russian market, Isconova is entitled to production and sales royalties.
For more information, please contact:
Lena Söderström, CEO Isconova
Phone: +46 70-816 39 12, e-mail: lena.soderstrom@isconova.com
About Isconova
Isconova AB is a Swedish research and development company with a patented technology that improves the effect and duration of vaccines. Isconova develops vaccines together with partners on the veterinary and human markets and has, since 2005, production and sales of vaccine systems on the veterinary market. www.isconova.com
About Matrix M™
Matrix M™ is Isconova’s patented adjuvant for use in vaccines for humans and some animals, antibody production and immunological research.
About adjuvants
Adjuvants are substances that improve the effect and duration of vaccines.
About Narvac
Narvac is one the largest medical developers and producers of veterinary products in Russia. Narvac produces vaccines, diagnostics and therapeuticals for cattle, small cattle, pigs and small animals. www.narvac.com